1文献来源Lancet JE,Uy GL,Newell LF,et al.CPX⁃351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high⁃risk or secondary acute myeloid leukaemia:5⁃year results of a randomised,o...1文献来源Lancet JE,Uy GL,Newell LF,et al.CPX⁃351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high⁃risk or secondary acute myeloid leukaemia:5⁃year results of a randomised,open⁃label,multicentre,phase 3 trial[J].Lancet Haematol,2021,8(7):e481-e491.2证据水平1b。3背景柔红霉素和阿糖胞苷被作为急性髓系白血病(acute myeloid leukaemia,AML)患者的标准诱导化疗。CPX⁃351是柔红霉素和阿糖胞苷协同包封的双药脂质体(摩尔比1∶5)。展开更多
文摘1文献来源Lancet JE,Uy GL,Newell LF,et al.CPX⁃351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high⁃risk or secondary acute myeloid leukaemia:5⁃year results of a randomised,open⁃label,multicentre,phase 3 trial[J].Lancet Haematol,2021,8(7):e481-e491.2证据水平1b。3背景柔红霉素和阿糖胞苷被作为急性髓系白血病(acute myeloid leukaemia,AML)患者的标准诱导化疗。CPX⁃351是柔红霉素和阿糖胞苷协同包封的双药脂质体(摩尔比1∶5)。
